MAY 10 - 11 2017
Genetics and Genomics 2017
41 127 27075

The 5th Annual Genetics and Genomics virtual conference is now On Demand. This event covers the most recent and exciting advances in genetics research. LabRoots invites research scientists, post docs, principal investigators, lab directors and other genetics professionals to learn about new discoveries and discuss their own findings with like-minded colleagues and experts in the field.

As the foundation of life, Genetics provides a base for other sciences to grow from. As we learn more about genetics and genomics applications, further knowledge can be integrated into diagnosis and treatment of disease and learning more about the complexities of human biology.

The topics discussed in this years Genetics and Genomics event includes:

  • Gene Therapy
  • Gene Modifiers and Disease Progression
  • Single Cell Genomics
  • Liquid Biopsies and Exosome
  • Precision Medicine

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so.

Genetics and Genomics conference participants benefit from interacting with field experts and networking with colleagues. Attendees can also “walk” through the virtual exhibit hall to learn about the latest in genetics and genomics tools and assays. Join LabRoots in leading progress toward understanding the genetics behind disease and treatment.

Continuing Education:
By participating in this virtual event and watching webcast presentations, you can earn Free CEU, PACE, and/or CME credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit. The American Board of Genetic Counseling, certifies genetic counselors and accredits genetic counseling training programs. The National Society of Genetic Counselors (NSGC) is the professional membership association for the genetic counseling profession.

Use #LRgenetics to follow the conversation


Speakers:
  • Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
  • Head of Clinical Genomics, Garvan Institute of Medical Research, Conjoint Associate Professor at the University of New South Wales
  • Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
  • Professor, Department of Bioengineering and Therapeutic Sciences, Institute for Human Genetics, UCSF
  • Associate Professor, Department of Biochemistry and Microbiology, Rutgers University
  • Instructor in Pediatrics, Boston Children's Hospital
  • Clinical Laboratory Director, Rady Children's Institute for Genomic Medicine
  • Albert L. Williams Professor of Biomedical Informatics, Co-Director, Yale Computational biology and Bioinformatics Program, Yale University
  • Chief Scientific Officer, Pacific Biosciences
  • the Molecular Biology Core Facility Manager, Geisel School of Medicine at Dartmouth
  • Assistant Professor, Department of Systems & Computational Biology, Assistant Professor, Department of Epidemiology & Population Health, Albert Einstein College of Medicine
  • Department Chair, Department of Systems Biology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
  • Clinical Director, Belfatrust
  • President, Coastal Genomics
  • Research Fellow, Dana-Farber Cancer Institute
  • Product Manager, Canon Biomedical
  • Vice President and Distinguished Scientist Illumina
  • Postdoctoral Scientist, German Cancer Research Center, Heidelberg
  • Associate Professor, Dept. of Biostatistics & Computational Biology, Dana-Farber Cancer Institute & Harvard T.H. Chan School of Public Health

Show Resources
Agenda
All times are Pacific Time
  • MAY 10, 2017 06:00 AM PDT
    CATS - a novel library preparation method for ultrasensitive deep sequencing of extracellular circulating RNA and DNA
    Speaker: Andrey Turchinovich, PhD
    Sponsored By: Diagenode
  • MAY 10, 2017 06:00 AM PDT
    Developing bioinformatics approaches to understand the functional consequences of gene expression variability
    Speaker: Jessica C Mar, PhD
  • MAY 10, 2017 07:30 AM PDT
    Enrichment of cffDNA and ctDNA via size selection for reduced diagnostic assay costs
    Speaker: Matthew Nesbitt, MSc
  • MAY 10, 2017 07:30 AM PDT
    Tough Targets. Simple Genotyping. - New Solutions for CRISPR, Mitochondrial Disease, Neurology, and Pharmacogenetic Research
    Speaker: Dana Pfister Sullivan
    Sponsored By: Canon BioMedical
  • MAY 10, 2017 09:00 AM PDT
    Keynote Presentation: Using Networks to Understand the Genotype-Phenotype Connection
    Speaker: John Quackenbush, PhD
  • MAY 10, 2017 10:30 AM PDT
    Delivering on the promise of Personalized Molecular Medicine
    Speaker: Gordon B Mills, MD, PhD
  • MAY 10, 2017 10:30 AM PDT
    Methods to account for sequencing artifacts in large high-throughput RNA-Seq data
    Speaker: Joseph Paulson, PhD
  • MAY 10, 2017 12:00 PM PDT
    Identifying genes "related to" or "specific for" a disease of interest
    Speaker: Philip Zimmerman, PhD
  • MAY 10, 2017 12:00 PM PDT
    Not all variants are created equal: what went wrong in the prediction of functional effects of exomic variation
    Speaker: Yana Bromberg, MD, PhD
  • MAY 10, 2017 01:30 PM PDT
    Addressing "NGS Dead Zones" with Third-Generation PacBio Sequencing
    Speaker: Jonas Korlach, PhD
  • MAY 10, 2017 01:30 PM PDT
    Mapping Cell States from Single-Cell Gene Expression Data
    Speaker: Guo-Cheng Yuan, MD
  • MAY 11, 2017 06:00 AM PDT
    Precision Medicine in Juvenile Psychosis
    Speaker: Catherine Brownstein, PhD
  • MAY 11, 2017 06:00 AM PDT
    Transcriptome Analysis; Tackling core issues related to regulation & also mining the "data exhaust" of this activity
    Speaker: Mark B Gerstein, PhD
  • MAY 11, 2017 07:30 AM PDT
    Keynote Presentation: Genomics in the clinic: A revolution for healthcare and medical research
    Speaker: Marcel Dinger, MSc (hons), PhD
  • MAY 11, 2017 09:00 AM PDT
    Keynote Presentation - Using network models to understand common complex disease predisposition and progression
    Speaker: Kenneth Buetow, PhD, FACMI
  • MAY 11, 2017 10:30 AM PDT
    Functional Characterization of Gene Regulatory Elements
    Speaker: Nadav Ahituv, PhD
  • MAY 11, 2017 10:30 AM PDT
    Rapid Whole Genome Sequencing in the NICU and PICU at Rady Children's Hospital
    Speaker: Shimul Chowdhury, PhD
  • MAY 11, 2017 12:00 PM PDT
    Impact of Next-Generation Sequencing on Precision Medicine
    Speaker: Gary Schroth,PhD
  • MAY 11, 2017 12:00 PM PDT
    New multiplexed nCounter® PlexSet™ Reagents- an alternative to qPCR technology
    Speaker: Christian Lytle
    Sponsored By: Nanostring Technologies
  • MAY 11, 2017 01:30 PM PDT
    Pandora's Genome: Making the Revolution Routine
    Speaker: Shane McKee, PhD
  • MAY 10, 2017 06:00 AM PDT
    CATS - a novel library preparation method for ultrasensitive deep sequencing of extracellular circulating RNA and DNA
    Speaker: Andrey Turchinovich, PhD
    Sponsored By: Diagenode
  • MAY 10, 2017 07:30 AM PDT
    Tough Targets. Simple Genotyping. - New Solutions for CRISPR, Mitochondrial Disease, Neurology, and Pharmacogenetic Research
    Speaker: Dana Pfister Sullivan
    Sponsored By: Canon BioMedical
  • Single Cell Genomics
  • MAY 10, 2017 06:00 AM PDT
    Developing bioinformatics approaches to understand the functional consequences of gene expression variability
    Speaker: Jessica C Mar, PhD
  • MAY 10, 2017 01:30 PM PDT
    Mapping Cell States from Single-Cell Gene Expression Data
    Speaker: Guo-Cheng Yuan, MD
  • Precision Medicine
  • MAY 10, 2017 07:30 AM PDT
    Enrichment of cffDNA and ctDNA via size selection for reduced diagnostic assay costs
    Speaker: Matthew Nesbitt, MSc
  • MAY 10, 2017 10:30 AM PDT
    Methods to account for sequencing artifacts in large high-throughput RNA-Seq data
    Speaker: Joseph Paulson, PhD
  • MAY 10, 2017 01:30 PM PDT
    Addressing "NGS Dead Zones" with Third-Generation PacBio Sequencing
    Speaker: Jonas Korlach, PhD
  • MAY 11, 2017 06:00 AM PDT
    Precision Medicine in Juvenile Psychosis
    Speaker: Catherine Brownstein, PhD
  • MAY 11, 2017 07:30 AM PDT
    Keynote Presentation: Genomics in the clinic: A revolution for healthcare and medical research
    Speaker: Marcel Dinger, MSc (hons), PhD
  • MAY 11, 2017 09:00 AM PDT
    Keynote Presentation - Using network models to understand common complex disease predisposition and progression
    Speaker: Kenneth Buetow, PhD, FACMI
  • MAY 11, 2017 12:00 PM PDT
    Impact of Next-Generation Sequencing on Precision Medicine
    Speaker: Gary Schroth,PhD
  • MAY 11, 2017 01:30 PM PDT
    Pandora's Genome: Making the Revolution Routine
    Speaker: Shane McKee, PhD
  • Gene Modifiers, Regulatory Elements and Disease Progression
  • MAY 10, 2017 09:00 AM PDT
    Keynote Presentation: Using Networks to Understand the Genotype-Phenotype Connection
    Speaker: John Quackenbush, PhD
  • MAY 11, 2017 10:30 AM PDT
    Functional Characterization of Gene Regulatory Elements
    Speaker: Nadav Ahituv, PhD
  • Gene Therapy
  • MAY 10, 2017 10:30 AM PDT
    Delivering on the promise of Personalized Molecular Medicine
    Speaker: Gordon B Mills, MD, PhD
  • MAY 10, 2017 12:00 PM PDT
    Identifying genes "related to" or "specific for" a disease of interest
    Speaker: Philip Zimmerman, PhD
  • MAY 11, 2017 10:30 AM PDT
    Rapid Whole Genome Sequencing in the NICU and PICU at Rady Children's Hospital
    Speaker: Shimul Chowdhury, PhD
  • MAY 11, 2017 12:00 PM PDT
    New multiplexed nCounter® PlexSet™ Reagents- an alternative to qPCR technology
    Speaker: Christian Lytle
    Sponsored By: Nanostring Technologies
  • Bioinformatics approaches
  • MAY 10, 2017 12:00 PM PDT
    Not all variants are created equal: what went wrong in the prediction of functional effects of exomic variation
    Speaker: Yana Bromberg, MD, PhD
  • Gene Modifiers and Disease Progression
  • MAY 11, 2017 06:00 AM PDT
    Transcriptome Analysis; Tackling core issues related to regulation & also mining the "data exhaust" of this activity
    Speaker: Mark B Gerstein, PhD
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

 

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

 

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

 

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster.  LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

 

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • John Quackenbush, PhD
    Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
    Biography
      John Quackenbush received his PhD in theoretical physics from UCLA in 1990. Following a physics postdoc, he received a Special Emphasis Research Career Award from the National Center for Human Genome Research to work on the Human Genome Project, spending two years at the Salk Institute and two years at Stanford University working in genomics and computational biology. In 1997 he moved to The Institute for Genomic Research (TIGR), pioneering expression analysis. He joined the Dana-Farber Cancer Institute and the Harvard School of Public Health in 2005, and works reconstruction of gene networks that drive the development of diseases. In 2012 he and Mick Correll co-Founded GenoSpace, a company that develops software tools to enable precision medicine applications. <br />
    • Marcel Dinger, MSc (hons), PhD
      Head of Clinical Genomics, Garvan Institute of Medical Research, Conjoint Associate Professor at the University of New South Wales
      Biography
        Marcel Dinger is the Head of Genome Informatics at the Garvan Institute of Medical Research and conjoint Associate Professor at UNSW Australia. After completing his PhD at the University of Waikato (New Zealand), he was awarded a NZ FoRST Postdoctoral Fellowship to join Professor Mattick's group at The University of Queensland to study the role of long noncoding RNAs in mammalian development and disease. He was recruited to the Garvan Institute in 2012.
      • Kenneth Buetow, PhD, FACMI
        Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
        Biography
          Dr. Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. Dr. Buetow currently serves as Director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU) and is a professor in the School of Life Sciences in ASU's College of Liberal Arts and Sciences. CAS@ASU applies systems approaches that leverage ASU's interdisciplinary research strengths to address complex global challenges. The Computational Sciences and Informatics program is developing and applying information technology to collect, connect, and enhance trans-disciplinary knowledge both within ASU and across the broader knowledge-generating ecosystems. CAS@ASU is creating a Next Generation Cyber Capability to address the challenges and opportunities afforded by "Big Data" and the emergence of 4th Paradigm Data Science. This capability brings state-of-the-art computational approaches to CAS@ASU's transdisciplinary, use-inspired research efforts Dr. Buetow previously served as the Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health's National Cancer Institute (NCI). In that capacity he initiated and oversaw the NCI's efforts to connect the global cancer community through community-developed, standards-based, interoperable informatics capabilities that enable secure exchange and use of biomedical data. Buetow designed and built one of the largest biomedical computing efforts in the world. He was responsible for coordinating biomedical informatics and information technology at the NCI. The NCI center he led focused on speeding scientific discovery and facilitated translational research by coordinating, developing and deploying biomedical informatics systems, infrastructure, tools and data in support of NCI research initiatives.
        • Nadav Ahituv, PhD
          Professor, Department of Bioengineering and Therapeutic Sciences, Institute for Human Genetics, UCSF
          Biography
            Dr. Nadav Ahituv is a Professor in the Department of Bioengineering and Therapeutic Sciences and the Institute for Human Genetics at the University of California, San Francisco. He received his PhD in human genetics from Tel-Aviv University working on hereditary hearing loss. He then did his postdoc, specializing in functional genomics, in the Lawrence Berkeley National Laboratory and the DOE Joint Genome Institute. His current work is focused on identifying gene regulatory elements and linking nucleotide variation within them to various phenotypes including morphological differences between species, drug response and human disease. In addition, his lab is developing massively parallel reporter assays (MPRAs) that allow for high-throughput functional characterization of gene regulatory elements.
          • Yana Bromberg, MD, PhD
            Associate Professor, Department of Biochemistry and Microbiology, Rutgers University
            Biography
              Dr. Yana Bromberg is an associate professor at the Department of Biochemistry and Microbiology, Rutgers University. She holds an adjunct position at the Department of Genetics at Rutgers and is the Chief Scientific Officer at BioSof - a company for bioinformatics tool development. She is also a fellow at the Institute of Advanced Studies in the Technical University of Munich. Dr. Bromberg received her Bachelor degrees in Biology and Computer Sciences from the State University of New York at Stony Brook and a Ph.D. in Biomedical Informatics from Columbia University, New York. She is known for her seminal work on a method for screening for non-acceptable polymorphisms, or SNAP for short, which evaluates the effects of single amino acid substitutions on protein function. Currently, research in the Bromberg lab is focused on the molecular functional annotation of microbiomes, aiming to identify emergent functionality specific to individual environmental niches. The lab also analyses human variomes for disease predisposition and the studies evolution of life's electron transfer reactions. Dr. Bromberg is a member of the Board of Directors of the International Society for Computational Biology and actively participates in organizing the ISMB/ECCB conferences (ISMB stands for Intelligent Systems for Molecular Biology, and ECCB is it's European equivalent). She chairs conference proceedings, conducts workshops, and organizes a special interest group aimed at the study of genomic variation - VarI-SIG. Dr. Bromberg's work has been recognized by several awards, including the recent NSF CAREER award, the TSS young investigator award from the American Society for Microbiology, the Rutgers Board of Trustees Research fellowship for Scholarly Excellence, the PhRMA foundation young investigator research starter award and the Hans-Fischer award for outstanding early career scientists from the Institute of Advanced Studies in Technical University of Munich. Dr. Bromberg also serves as an editor and a reviewer of several top bioinformatics journals, including BMC Genomics and PLoS Computational Biology. To date, she has authored or co-authored over 40 peer reviewed scientific articles and has been invited to give over 80 talks.
            • Catherine Brownstein, PhD
              Instructor in Pediatrics, Boston Children's Hospital
              Biography
                Catherine Brownstein is a geneticist and toxicologist with eleven years experience in human genetics and three years in applying patient-reported outcomes to the study of disease. She has been project manager of the Research Sequencing Program at Boston Children's Hospital since 2011. Her research career includes training in genetics, medical genetics, epidemiology, and environmental health. She has also completed MPH at the Yale School of Epidemiology and Public Health and worked as a toxicologist at the Massachusetts Department of Public Health. Before coming to BCH and HMS, she spent four years creating online patient communities for individuals with chronic or terminal diseases.
              • Shimul Chowdhury, PhD
                Clinical Laboratory Director, Rady Children's Institute for Genomic Medicine
                Biography
                  Shimul Chowdhury serves as a clinical laboratory director at the Rady Children's Institute for Genomic Medicine (RCIGM). Prior to joining the RCIGM team, Dr. Chowdhury served as a Senior Scientist in the Illumina Clinical Services Laboratory in which he reviewed and analyzed patient genomes for rare and undiagnosed disease as well as healthy individuals. Dr. Chowdhury has also served as a clinical laboratory director at Quest Diagnostics. Dr. Chowdhury is licensed as a clinical laboratory director for molecular genetics by the state of California. He conducted his American Board of Medical Genetics and Genomics (ABMGG) clinical molecular genetics fellowship at Sacred Heart Medical Center in Spokane, Washington. He obtained his PhD in Clinical and Translational Sciences at the University of Arkansas for Medical Sciences, and his Bachelors of Science at the University of Minnesota- Twin Cities. He is an active member of the Association for Molecular Pathology, the American Society of Human Genetics and is a fellow of the American College of Medical Genetics and Genomics.
                • Mark B Gerstein, PhD
                  Albert L. Williams Professor of Biomedical Informatics, Co-Director, Yale Computational biology and Bioinformatics Program, Yale University
                  Biography
                      Mark Gerstein is the Albert L Williams professor of Biomedical Informatics at Yale University. He is co-director the Yale Computational Biology and Bioinformatics Program, and has appointments in the Department of Molecular Biophysics and Biochemistry and the Department of Computer Science. He received his AB in physics summa cum laude from Harvard College and his PhD in chemistry from Cambridge. He did post-doctoral work at Stanford and took up his post at Yale in early 1997. Since then he has published appreciably in scientific journals. He has >400 publications in total, with a number of them in prominent journals, such as Science, Nature, and Scientific American. (His current publication list is at http://papers.gersteinlab.org .) His research is focused on bioinformatics, and he is particularly interested in large-scale integrative surveys, biological database design, macromolecular geometry, molecular simulation, human genome annotation, gene expression analysis, and data mining.     
                  • Jonas Korlach, PhD
                    Chief Scientific Officer, Pacific Biosciences
                    Biography
                      Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 70 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                    • Christian Lytle
                      the Molecular Biology Core Facility Manager, Geisel School of Medicine at Dartmouth
                      Biography
                        Christian H. Lytle is the Molecular Biology Core Facility Manager at Geisel School of Medicine at Dartmouth. He has more than 30 years of research experience in various roles and is affiliated with societies such as The Association of Bimolecular Resource Facilities (ABRF). He has received many awards and recognitions for his work in the genomics field.
                      • Jessica C Mar, PhD
                        Assistant Professor, Department of Systems &amp; Computational Biology, Assistant Professor, Department of Epidemiology &amp; Population Health, Albert Einstein College of Medicine
                        Biography
                          Jessica Mar is an Assistant Professor at the Albert Einstein College of Medicine in the Department of Systems and Computational Biology in the Bronx, New York. The Mar lab investigates how variability of gene expression informs our understanding of how genes and pathways are dysregulated in disease. Dr. Mar received her PhD in Biostatistics from Harvard University in 2008. Previously she was a postdoctoral research fellow at the Dana-Farber Cancer Institute in Boston and a visiting scientist at the European Bioinformatics Institute in the United Kingdom. She is a recipient of a University of Queensland medal and an American-Australian Fulbright award. She is currently an Associate Editor of Genomics.
                        • Gordon B Mills, MD, PhD
                          Department Chair, Department of Systems Biology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
                          Biography
                            Gordon B. Mills, MD, PhD, was recruited to The University of Texas M. D. Anderson Cancer Center in 1994, where he holds the rank of Professor with joint appointments in Systems Biology, Breast Medical Oncology and Immunology; serves as chairman of the Department of Systems Biology; head of the section of Molecular Therapeutics and holds the Wiess Distinguished University Chair in Cancer Medicine. Dr. Mills is co-Director of the Kleberg Center for Molecular Markers and Director for the Gita and Ali Saberioon Molecular Markers building. This Center is responsible for developing personalized molecular medicine at MDACC. Dr. Mills has published extensively on the molecular analysis of cancer and currently serves as principal investigator or project investigator on many national peer review grants including NIH/NCI SPOREs and PPGs, Department of Defense, and Komen Foundation grants, and is a collaborator on multiple other national grants. Dr. Mills also holds more than 20 patents related to novel technologies and molecular markers and has co-founded an early diagnostics company. He currently sits on the scientific advisory boards of multiple companies and venture capital groups. Based on his expertise in technology development, he is the head of the M. D. Anderson Cancer Center Technology Review Committee.    
                          • Shane McKee, PhD
                            Clinical Director, Belfatrust
                            Biography
                              Dr Shane McKee is a Consultant in Genetic Medicine at Belfast Health & Social Care Trust in Northern Ireland. He has a long-standing clinical and research interest in the diagnosis and management of ultra-rare genetic syndromes and neurodevelopmental conditions. He has been heavily involved in the DDD (Deciphering Developmental Disorders) Study, which sequenced the exomes of almost 14,000 patients in the UK to determine the genetic architecture of birth defects and intellectual disability presenting in UK clinics. He is currently Principal Investigator for the Northern Ireland contribution to the UK 100,000 Genomes Initiative, and is working with colleagues to advance genomic testing in NI, making it more accessible as a diagnostic tool. His other main interest is in the use of digital technology to improve healthcare, and he is the Chief Clinical Information Officer for the Belfast Trust.
                            • Matthew Nesbitt, MSc
                              President, Coastal Genomics
                              Biography
                                Mr. Nesbitt completed his Masters degree in Molecular Biology at Simon Fraser University where his work focused on the discovery of new genes in the C. elegans model organism. This experience impressed upon him both the value of next generation sequencing and its vulnerabilities to the extensively manual sample preparation steps. Mr. Nesbitt started his professional career in liquid handling automation as a product manager responsible for the development of NGS library construction solutions. He now works with Coastal Genomics to launch its automated gel size electrophoresis solution, Ranger Technology. <br />
                              • Joseph Paulson, PhD
                                Research Fellow, Dana-Farber Cancer Institute
                                Biography
                                  I am a Research Fellow in the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute and Department of Biostatistics at the Harvard TH Chan School of Public Health under the guidance of Professor John Quackenbush. Prior to joining Harvard I was a National Science Foundation Graduate Research Fellow at the University of Maryland, College Park where I received my Ph.D. in Applied Mathematics, Statistics and Scientific Computation. As a computer scientist and computational biologist, my interests are to develop computational methods for the analysis of high-throughput sequencing data. I also desire to develop software and support these methods as open-source software for the broader scientific community through Bioconductor and popular domain tools such as QIIME and Phyloseq. MetagenomeSeq, is my most popular tool developed and is in the top 5% of all Bioconductor packages downloaded in the last year with over 5,000 unique users. I am excited to leverage statistical and network methodologies in accounting for technological when identifying disease markers.
                                • Dana Pfister Sullivan
                                  Product Manager, Canon Biomedical
                                  Biography
                                    Dana Pfister Sullivan received her Masters in Biotechnology, from Johns Hopkins University, with a focus in molecular targets and drug design. She has worked in various areas of the biotechnology industry, including pharmaceutical, life science, and molecular diagnostic in both research and development as well as commercial. Dana has five years of practical experience at the laboratory bench, and her work has been published in peer-reviewed journals and presented at international conferences. Dana joined Canon BioMedical as Product Manager shortly after the first launch of the Novallele Genotyping Assays. She is passionate about partnering with life scientists and researchers to develop the next wave of biomedical solutions.
                                  • Gary Schroth,PhD
                                    Vice President and Distinguished Scientist Illumina
                                    Biography
                                      Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he directs the Core Applications Group based in San Diego. He obtained his Ph.D. in biochemistry from the University of California at Davis and has been working in the field of next-generation sequencing (NGS) for more than a decade as part of Illumina (and Solexa). In his research Dr. Schroth uses NGS to study genomics, gene structure, expression and regulation and applies this to genomic projects in the fields of cancer, microbiology and infectious disease. Over the course of his career Dr. Schroth has published over 90 peer reviewed research papers and holds 17 U.S. patents.
                                    • Andrey Turchinovich, PhD
                                      Postdoctoral Scientist, German Cancer Research Center, Heidelberg
                                      Biography
                                        Andrey Turchinovich received his PhD in Neuroscience at Ruhr-University Bochum, where his research was concentrated on RNA interference and functional analysis of genes involved in neurodegeneration. He is currently working as a postdoctoral scientist at the German Cancer Research Center in Heidelberg. His research is focused on developing new methods for early diagnosis of tumors based on extracellular circulating RNA and DNA. Among his major achievements is developing a novel DNA library preparation method which allows deep sequencing of ultra-low inputs of nucleic acids and detection of circulating DNA and RNA in bio-fluids with unprecedented sensitivity. Furthermore, together with his colleagues, he has previously explained the origin and the stability of extracellular circulating microRNAs.
                                      • Guo-Cheng Yuan, MD
                                        Associate Professor, Dept. of Biostatistics & Computational Biology, Dana-Farber Cancer Institute & Harvard T.H. Chan School of Public Health
                                        Biography
                                          Guo-Cheng Yuan received his B.Sc and M.A. degrees from Peking University, China, and his Ph.D. in Mathematics from University of Maryland at College Park. Dr. Yuan's prior work experience spanned diverse fields including chaos theory and weather prediction. He did postdoctoral training in Computational Biology at Harvard University. He is currently an Associate Professor at the Department of Biostatistics and Computational Biology at Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health.
                                        • Philip Zimmerman, PhD
                                          CEO, Nebion
                                          Biography
                                            Philip Zimmerman pursued a PhD in molecular biology. His post doctoral research focused on genetic regulatory networks and meta-profile analysis. As CEO of Nebion, he is responsible for business development and marketing.
                                          Sponsored By

                                          For information on becoming a sponsor or exhibitor, please click here.


                                          Continuing Education (CME/CE/CEU) Credits

                                          The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                                          The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material is geared towards Primary Care Clinicians, All Health Care Professionals, including Genetic Counselors, PAs, LPNs, NPs, RNs, Clinical Geneticists, Physicians in practice, Genetics Researchers, and others. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, and Systems-Based Practice.
                                          Desired Outcomes

                                          At the end of the activity, participants should be able to:

                                          • Integrate genetic medicine into practice in ways that are consistent with acknowledged practice guidelines and that improve patient management and outcomes
                                          • Integrate genetic technologies currently available for use in the clinic and the limitations of these technologies
                                          • Apply current and established medical science principles to patient care, including utilization of information in personal and family histories that indicate a need for genetic testing
                                          • Perform continuous self-assessment and learning to improve one’s professional and clinical practices, including how to interpret results in ways most useful to the patient and when to refer to specialized genetic services

                                          This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Institute for Medical Quality/California Medical Association (IMQ/CMA) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the IMQ/CMA to provide continuing medical education for physicians. CME Consultants designated this internet live course and this internet activity enduring material for a maximum of 5.0 AMA PRA Category 1 CreditsTM .Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                          The National Society of Genetic Counselors (NSGC) has authorized LabRoots to offer up to 1.00 CEUs or 10.00 Category 1 contact hours for the event 2017 Genetics and Genomics virtual event. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

                                          Enduring Material release date: 5/12/17

                                          Enduring Material Termination date: 11/12/17

                                          In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.


                                          Committee

                                          To download the Program Committee brochure here.


                                          • Shawn Baker, PhD

                                            Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                            See more See less
                                          • Pinar Bayrak-Toydemir, MD, PhD

                                            Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                            See more See less
                                          • Agnieszka Lichanzka Ph.D.

                                            Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                            See more See less
                                          • C Jimmy Lin, MD, PhD, MHS

                                            Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                            See more See less
                                          • John Quackenbush, PhD

                                            John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                            See more See less
                                          • Ann Murray, LVT, LATG

                                            Ann graduated from Newbury College in Boston MA with a Veterinary Technology degree in 1984. She worked in clinical veterinary practice for three years and then joined Georgetown University Research Resources Facility in Washington DC from 1987-2000, with increasing ...

                                            See more See less
                                          Help

                                          General LabRoots Questions

                                          For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                          Contact us

                                          Virtual Events and Webinars

                                          Supported Configurations

                                          • Operating System Internet Explorer Firefox Chrome Safari
                                            Vista IE8+ FF10+ Chrome15+
                                            Windows 7 IE8+ FF10+ Chrome15+
                                            Windows 8 IE10 FF10+ Chrome15+
                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                          • Cookie settings: session cookies enabled
                                          • Browser configuration must have JavaScript enabled
                                          • Adobe Flash player 10.2 or later

                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                          Internet Connection

                                          • A minimum of 100Kbps is recommended for audio-only events
                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                          Computer Equipment

                                          • Screen Resolution: Minimum 1024x768
                                          • Video Card: 65,000 colors minimum
                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                          • Audio Card: 16-bit minimum
                                          • RAM: 512MB of free RAM

                                          Firewall Protocol

                                          • HTTP on port 80 or HTTPS on port 443
                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                          Work-At-Home Attendees

                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                          For A Seamless Experience

                                          When using a mobile device, FREE Mobile Apps are available:

                                          - For viewing Webinars:

                                          - For viewing Virtual Events

                                          Attendee Guide

                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                          Virtual Event and Webinar Support:

                                          Continuing Education (CME/CE) Support

                                          Loading Comments...
                                          Show Resources